A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Study sponsor: Zenas BioPharma (USA), LLC
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-08-28Actual
Enrollment · participants93Estimated
Source updated2025-11-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.